Drug delivery strategy in hepatocellular carcinoma therapy

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, with high rates of recurrence and death. Surgical resection and ablation therapy have limited efficacy for patients with advanced HCC and poor liver function, so pharmacotherapy is the first-line option for those pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sisi, Cai, Chengwei, Wang, Huanqiu, Ma, Xueqing, Shao, Anwen, Sheng, Jifang, Yu, Chengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898478/
https://www.ncbi.nlm.nih.gov/pubmed/35248060
http://dx.doi.org/10.1186/s12964-021-00796-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898478/
https://www.ncbi.nlm.nih.gov/pubmed/35248060
http://dx.doi.org/10.1186/s12964-021-00796-x

Ejemplares similares